Clinicians may be uncertain regarding the optimal strategy for insulin intensification [20] or favor resorting to less widely used treatment approaches to meet the needs of individual patients [5], as personalized diabetes management is becoming important. This evidence concerns the gene INS and diabetes mellitus.